Literature DB >> 15917513

Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis.

Mark T McCammon1, John S Gillette, Derek P Thomas, Srinivas V Ramaswamy, Edward A Graviss, Barry N Kreiswirth, Jan Vijg, Teresa N Quitugua.   

Abstract

Denaturing gradient gel electrophoresis (DGGE) was used to probe for mutations associated with rifampin (RIF) resistance in the rpoB gene of Mycobacterium tuberculosis. DGGE scans for mutations across large regions of DNA and is comparable to DNA sequencing in detecting DNA alterations. Specific mutations are often recognized by their characteristic denaturation pattern, which serves as a molecular fingerprint. Five DGGE primer sets that scanned for DNA alterations across 775 bp of rpoB were developed. These primer sets were used to scan rpoB for DNA alterations in 296 M. tuberculosis patient isolates from the United States-Mexico border states of Texas and Tamaulipas. The most useful primer set scanned for mutations in the rifampin resistance-determining region (RRDR) and detected mutations in 95% of the RIF-resistant isolates compared to 2% of RIF-susceptible isolates. Thirty-four different alterations were observed within the RRDR by DGGE. In addition, isolates harboring mixtures of DNA within rpoB were readily detected by DGGE. A second PCR primer set was used to detect the V146A mutation in 5 to 7% of RIF-resistant isolates. A third primer set was used to detect mutations in 3% of RIF-resistant isolates, some of which also harbored mutations in the RRDR. Only 1 of 153 RIF-resistant isolates did not have a detectable rpoB mutation as determined by DGGE and DNA sequencing. These results demonstrate the power and usefulness of DGGE in detecting mutations associated with drug resistance in M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917513      PMCID: PMC1140537          DOI: 10.1128/AAC.49.6.2200-2209.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  DGGE is more sensitive for the detection of somatic point mutations than direct sequencing.

Authors:  B Trülzsch; K Krohn; P Wonerow; R Paschke
Journal:  Biotechniques       Date:  1999-08       Impact factor: 1.993

Review 2.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

3.  High-speed, multicolor fluorescent two-dimensional gene scanning.

Authors:  S B McGrath; M Bounpheng; L Torres; M Calavetta; C B Scott; Y Suh; D Rines; N van Orsouw; J Vijg
Journal:  Genomics       Date:  2001-11       Impact factor: 5.736

Review 4.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 5.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

6.  Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  M Heep; B Brandstätter; U Rieger; N Lehn; E Richter; S Rüsch-Gerdes; S Niemann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia.

Authors:  L K Yuen; D Leslie; P J Coloe
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

8.  Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.

Authors:  Mark T McCammon; John S Gillette; Derek P Thomas; Srinivas V Ramaswamy; Ishmael I Rosas; Edward A Graviss; Jan Vijg; Teresa N Quitugua
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 9.  Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications.

Authors:  Thomas C Victor; Paul D van Helden; Robin Warren
Journal:  IUBMB Life       Date:  2002 Apr-May       Impact factor: 3.885

10.  rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism.

Authors:  M Bobadilla-del-Valle; A Ponce-de-Leon; C Arenas-Huertero; G Vargas-Alarcon; M Kato-Maeda; P M Small; P Couary; G M Ruiz-Palacios; J Sifuentes-Osornio
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  28 in total

1.  Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.

Authors:  Xiaoyou Chen; Fanrong Kong; Qinning Wang; Chuanyou Li; Jianyuan Zhang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.

Authors:  Zohar B Weinstein; Muhammad H Zaman
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.

Authors:  Janice C Caoili; Angelina Mayorova; David Sikes; Laura Hickman; Bonnie B Plikaytis; Thomas M Shinnick
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.

Authors:  Paolo Miotto; Federica Piana; Valeria Penati; Filippo Canducci; Giovanni Battista Migliori; Daniela Maria Cirillo
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains.

Authors:  Luke T Daum; John D Rodriguez; Sue A Worthy; Nazir A Ismail; Shaheed V Omar; Andries W Dreyer; P Bernard Fourie; Anwar A Hoosen; James P Chambers; Gerald W Fischer
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

6.  Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis.

Authors:  Jimena Collantes; Francesca Barletta Solari; Leen Rigouts
Journal:  Am J Trop Med Hyg       Date:  2016-10-24       Impact factor: 2.345

Review 7.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

8.  Evaluation of the rpoB macroarray assay to detect rifampin resistance in Mycobacterium tuberculosis in Beijing, China.

Authors:  I Mokrousov; W W Jiao; G Z Sun; J W Liu; M Li; O Narvskaya; A D Shen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

9.  Capillary electrophoresis-single strand conformation polymorphism for the detection of multiple mutations leading to tuberculosis drug resistance.

Authors:  Sowmya Krothapalli; Michael K May; Christa N Hestekin
Journal:  J Microbiol Methods       Date:  2012-08-03       Impact factor: 2.363

10.  Sequence polymorphisms in a surface PPE protein distinguish types I, II, and III of Mycobacterium avium subsp. paratuberculosis.

Authors:  Tanya A Griffiths; Kevin Rioux; Jeroen De Buck
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.